Comment on: Possible miliary tuberculosis during adalimumab therapy with negative γ-IFN release assays

Rheumatology

Volumn 48, Issue 9, 2009, Pages 1177-1178

  Mangat, Pamela ^a,b   Taylor, Peter ^a,b   Abraham, Sonya ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETHAMBUTOL; GAMMA INTERFERON; RIFATER; MONOCLONAL ANTIBODY;

BACTERIUM CULTURE; BACTERIUM ISOLATION; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LEUKOPENIA; MILIARY TUBERCULOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MARINUM; MYCOBACTERIUM SZULGAI; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; BIOSYNTHESIS; DIFFERENTIAL DIAGNOSIS; MYCOBACTERIOSIS; NOTE; OPPORTUNISTIC INFECTION;

ANTIBODIES, MONOCLONAL; DIAGNOSIS, DIFFERENTIAL; HUMANS; INTERFERON-GAMMA; MYCOBACTERIUM INFECTIONS; OPPORTUNISTIC INFECTIONS; TUBERCULOSIS, MILIARY;

EID: 70349783206     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep163     Document Type: Letter

References (5)

1. Endean AL, Barry SM, Young-Min SA. Possible miliary tuberculosis during adalimumab therapy with negative γ-IFN release assays. Rheumatology 2009; 48:319-20.
2. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000;356:1099-104.
3. Hornum M, Mortensen KL, Kamper AL, Anderson AB. Limitations of the QuantiFERON-TB Gold test in detecting Mycobacterium tuberculosis infection in immunocompromised patients. Eur J Intern Med 2008;19:137-9.
4. Pai M, Zwerling A, Menzies D. Systematic review: T-cell based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149:177-84.
5. Piana F, Codecasa LR, Cavallerio P et al. Use of α T-cell-based test for detection of tuberculosis infection among immunocompromised patients. Eur Respir J 2006;28:31-4.